Inari Medical gets FDA approval for FlowTriever system to treat CIT
Inari Medical has received the US Food and Drug Administration (FDA) 510(k) approval for its FlowTriever system to treat pulmonary embolism and right atrial clot in transit (CIT).
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XInari Medical has received the US Food and Drug Administration (FDA) 510(k) approval for its FlowTriever system to treat pulmonary embolism and right atrial clot in transit (CIT).
Italy-based ophthalmic company SIFI has rolled out its novel medical device SYNFO, for the treatment of dry eyes disease. Being the latest addition to the company’s dry eye
Cleveland, Ohio-based medical device company Neuros Medical has secured a total of $38.5m in a Series BB financing round, jointly led by existing and new investors. New investors
Locate Bio, an advanced orthobiologics firm, has secured the US Food and Drug Administration (FDA) Breakthrough Device designation for its bone graft product CognitOss. CognitOss is currently under
Dräger, an international leader in the fields of medical and safety technology, today announced that it has entered into an agreement with Breas Medical, a global medical device
Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader in digital therapeutics, announced today the Company has signed a partnership agreement with Cognitive Apps Software Solutions Inc. (Cognitive
Rimsys, a world-leading Regulatory Information Management (RIM) software platform for medical technology companies, announced the release of an innovative and automated solution to address the global Unique Device
French medical device firm CorWave has secured $40m funding in a Series C financing round, to support the development of its implantable heart pump. The financing round saw
SOLVD Health, previously called Prescient Medicine, is planning to begin a clinical trial to evaluate LifeKit Prevent, its non-invasive colorectal cancer (CRC) screening test, in the US. The
Henry Schein, a provider of health care solutions to office-based dental and medical practitioners, has acquired a majority stake in Prism Medical Products (PRISM). Established in 2006, in